TANANBAUM JAMES B. purchased 7.5% of their position (140K shares) of LATIGO BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $2.52M — a moderate purchase. The strongest form of insider conviction signal.
Common Stock
Shares
+3.12M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+445.32K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.13M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+742.20K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+140K
Price / share
$18.00
Trade value
$2.52M
% of position
Common Stock
Shares
+195.78K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+3.12M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+296.88K
Price / share
—
Trade value
—
% of position
Net shares
+9.18M
Net value
$2.52M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/10/2026 | C · Conversion | +3.12M | — | — | New position | 0.00 | 3.12M |
| Common Stock Indirect | 8/10/2026 | C · Conversion | +445.32K | — | — | 14.3% | 3.12M | 3.56M |
| Common Stock Indirect | 8/10/2026 | C · Conversion | +1.13M | — | — | New position | 0.00 | 1.13M |
| Common Stock Indirect | 8/10/2026 | C · Conversion | +742.20K | — | — | 65.9% | 1.13M | 1.87M |
| Common Stock Indirect | 8/10/2026 | P · Purchase | +140K | $18.00 | $2.52M | 7.5% | 1.87M | 2.01M |
| Common Stock Indirect | 8/10/2026 | C · Conversion | +195.78K | — | — | 9.7% | 2.01M | 2.20M |
| Common Stock Indirect | 8/10/2026 | C · Conversion | +3.12M | — | — | New position | 0.00 | 3.12M |
| Common Stock Indirect | 8/10/2026 | C · Conversion | +296.88K | — | — | 9.5% | 3.12M | 3.41M |
| Total | +9.18M | $2.52M | ||||||
Series A-2 Convertible Stock
Common Stock
3.12M shares
Shares
−3.12M
Strike price
Held after
0.00
Exercisable
—
Series B Convertible Preferred Stock
Common Stock
445.32K shares
Shares
−445.32K
Strike price
Held after
0.00
Exercisable
—
Series A-2 Convertible Preferred Stock
Common Stock
1.13M shares
Shares
−1.13M
Strike price
Held after
0.00
Exercisable
—
Series B Convertible Preferred Stock
Common Stock
742.20K shares
Shares
−742.20K
Strike price
Held after
0.00
Exercisable
—
Series A-2 Convertible Preferred Stock
Common Stock
3.12M shares
Shares
−3.12M
Strike price
Held after
0.00
Exercisable
—
Series B Convertible Preferred Stock
Common Stock
296.88K shares
Shares
−296.88K
Strike price
Held after
0.00
Exercisable
—
Convertible Promissory Note
Common Stock
195.78K shares
Shares
−195.78K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A-2 Convertible Stock Indirect | Common Stock3.12M shares | 8/10/2026 | C · Conversion | −3.12M | — | 0.00 | |
| Series B Convertible Preferred Stock Indirect | Common Stock445.32K shares | 8/10/2026 | C · Conversion | −445.32K | — | 0.00 | |
| Series A-2 Convertible Preferred Stock Indirect | Common Stock1.13M shares | 8/10/2026 | C · Conversion | −1.13M | — | 0.00 | |
| Series B Convertible Preferred Stock Indirect | Common Stock742.20K shares | 8/10/2026 | C · Conversion | −742.20K | — | 0.00 | |
| Series A-2 Convertible Preferred Stock Indirect | Common Stock3.12M shares | 8/10/2026 | C · Conversion | −3.12M | — | 0.00 | |
| Series B Convertible Preferred Stock Indirect | Common Stock296.88K shares | 8/10/2026 | C · Conversion | −296.88K | — | 0.00 | |
| Convertible Promissory Note Indirect | Common Stock195.78K shares | 8/10/2026 | C · Conversion | −195.78K | — | 0.00 |